PRS40 THE IMPACT OF THE FDAS RISK EVALUATION AND MITIGATION STRATEGIES (REMS) INITIATIVE ON PRESCRIPTION PATTERN FOR DRUGS APPROVED UNDER THE REMS PROGRAM AND RELEVANT NON-REMS COMPETITORS
Abstract
Authors
N Horowicz-Mehler B Sepulveda C White J Doyle